Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
andecaliximab matrix metalloproteinase-9 NA Clinical trial target TTD , DGIDB Adenocarcinoma[MeSHID:D000230]
Malignant Neoplasms[MeSHID:D009369]
Stomach[MeSHID:D013270]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
12.73 phase 3 unknown
andecaliximab matrix metalloproteinase-9 NA Clinical trial target TTD , DGIDB Adenocarcinoma[MeSHID:D000230]
Malignant Neoplasms[MeSHID:D009369]
Stomach[MeSHID:D013270]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
12.73 phase 3 inhibitor
andecaliximab matrix metalloproteinase-9 NA Clinical trial target TTD , DGIDB Adenocarcinoma[MeSHID:D000230]
Malignant Neoplasms[MeSHID:D009369]
Stomach[MeSHID:D013270]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
12.73 phase 3 antibody
click here to return to the previous page